GERMANTOWN, Maryland and HILDEN, Germany, May 25, 2010 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that it has entered into an agreement with the Institute for Product Quality (ifp), pursuant to which QIAGEN has acquired all rights to 70 molecular food safety tests developed by the Berlin-based specialized laboratory center for food analysis. The transaction further strengthens QIAGEN's "Applied Testing" business segment, which also encompasses molecular testing systems for forensic applications, veterinary medicine and biodefense. No financial details were disclosed.
The tests acquired from ifp are based on the widely used real-time PCR (Polymerase Chain Reaction) technology and cover a broad range of molecular targets including genetic, bacterial, viral and other contaminants of foodstuffs. The tests can be fully automated using QIAGEN's own instruments such as the QIAsymphony and the Rotor-Gene Q. The transaction enables QIAGEN to offer complete solutions for all major applications in the food safety testing segment, covering entire workflows from the processing of primary samples to the final testing result.
"With this unique assay portfolio we are laying the foundation for a very
strong position in the area of food safety testing and significantly
strengthening the area of applied testing overall," said Peer Schatz, Chief
Executive Officer of QIAGEN. "Applied testing represents an important growth
area for our company. Here, we are focusing on select segments with a
relevant market volume, a growing
Copyright©2010 PR Newswire.
All rights reserved